Rating Watching: Pacira Pharmaceuticals (NASDAQ:PCRX) Gets Coverage From H.C. Wainwright with $43.00 PT - Thorold News

Thorold News
Rating Watching: Pacira Pharmaceuticals (NASDAQ:PCRX) Gets Coverage From H.C. Wainwright with $43.00 PT
Thorold News
H.C. Wainwright issued a “Buy” rating on Pacira Pharmaceuticals (NASDAQ:PCRX). The firm has begun coverage on shares of PCRX in a a note revealed to investors on Tuesday morning. H.C. Wainwright's target price suggests upside of 28.74% from the ...
H.C. Wainwright Starts Pacira Pharmaceuticals (PCRX) at BuyStreetInsider.com
Pacira Pharmaceuticals, In